(Q44323025)

2 December 2017

title

Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy (English)

1 reference

2 December 2017

main subject

ventricular remodeling

1 reference

Shu Kasama

1

1 reference

2 December 2017

Takuji Toyama

2

1 reference

2 December 2017

Hisao Kumakura

3

1 reference

2 December 2017

Yoshiaki Takayama

4

1 reference

2 December 2017

Shuichi Ichikawa

5

1 reference

2 December 2017

Tadashi Suzuki

6

1 reference

2 December 2017

Masahiko Kurabayashi

7

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Journal of the American College of Cardiology

2 December 2017

published in

1 reference

2 December 2017

volume

41

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

574-581

1 reference

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Aldosterone and antialdosterone therapy in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Chronic administration of aldosterone depresses baroreceptor reflex function in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Serial change of iodine-123 metaiodobenzylguanidine (MIBG) myocardial concentration in patients with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Remodeling of the rat right and left ventricles in experimental hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Role of mechanical and hormonal factors in cardiac remodeling and the biologic limits of myocardial adaptation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

QT dispersion and sudden unexpected death in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Clinical usefulness of 123I meta-iodobenzylguanidine imaging in predicting the effectiveness of beta blockers for patients with idiopathic dilated cardiomyopathy before and soon after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Segmental pattern of myocardial sympathetic denervation in idiopathic dilated cardiomyopathy: relationship to regional wall motion and myocardial perfusion abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Comparison of parameters of 123I-MIBG scintigraphy for predicting prognosis in patients with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Aldosterone production is activated in failing ventricle in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

Expression of aldosterone synthase gene in failing human heart: quantitative analysis using modified real-time polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902855-3

7 January 2021

10.1016/S0735-1097(02)02855-3

Identifiers

DOI

1 reference

2 December 2017

1 reference